Mast cell proliferative disorders: current view on variants recognized by the World Health Organization

被引：56

作者：

Valent, P

Akin, C

Sperr, WR

Horny, HP

Metcalfe, DD

机构：

[1] Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria

[2] NIH, Lab Allerg Dis, Bethesda, MD 20892 USA

[3] Med Univ Lubeck, Inst Pathol, D-23538 Lubeck, Germany

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2003年 / 17卷 / 05期

关键词：

D O I：

10.1016/S0889-8588(03)00089-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Mastocytosis is a heterogeneous group of disorders characterized by abnormal growth and accumulation of mast cells in one or more organs. Systemic variants of disease can be regarded as myeloproliferative disorders. Similar to other myeloid neoplasms, systemic mastocytosis shows a variable clinical course and prognosis and can progress into frank leukemia. The treatment of mastocytosis must be adjusted to the individual situation in each patient and the subtype of disease.

引用

页码：1227 / +

页数：16

共 95 条

[1] AGIS H, 1993, J IMMUNOL, V151, P4221
[2] Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis
Akin, C
Kirshenbaum, AS
Semere, T
Worobec, AS
Scott, LM
Metcalfe, DD
[J]. EXPERIMENTAL HEMATOLOGY, 2000, 28 (02) : 140 - 147
[3] Surrogate markers of disease in mastocytosis
Akin, C
Metcalfe, DD
[J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2002, 127 (02) : 133 - 136
[4] Slowly progressive systemic mastocytosis with high mast-cell burden and no evidence of a non-mast-cell hematologic disorder: an example of a smoldering case?
Akin, C
Scott, LM
Metcalfe, DD
[J]. LEUKEMIA RESEARCH, 2001, 25 (07) : 635 - 638
[5] SYSTEMIC MASTOCYTOSIS
AUSTEN, KF
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (09) : 639 - 640
[6] Beltrani G, 1966, Minerva Dermatol, V41, P436
[7] Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis:: A possible explanation for divergent clinical behavior
Büttner, C
Henz, BM
Welker, P
Sepp, NT
Grabbe, J
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (06) : 1227 - 1231
[8] NATURAL COURSE OF URTICARIA PIGMENTOSA - ANALYSIS AND FOLLOW-UP 112 CASES
CAPLAN, RM
[J]. ARCHIVES OF DERMATOLOGY, 1963, 87 (02) : 146 - &
[9] Mastocytosis: Mediator-related signs and symptoms
Castells, M
Austen, KF
[J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2002, 127 (02) : 147 - 152
[10] Cohn Monique S., 1994, Journal of the American Osteopathic Association, V94, P246

← 1 2 3 4 5 6 7 8 9 10 →